Ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with Β-ketoacyl-Acp synthase (KasA) in potential anti-tubercular drug designing

Mycobacterium tuberculosis remains one of the world's contributors to mortality. With the emergence of SARS-CoV-2 coinfections, patients with TB are predisposed to being more heavily weighed down by COVID-19 disease and its opportunistic coinfections. The severity of the disease coupled with dr...

Full description

Bibliographic Details
Main Authors: Andrew G. Mtewa, Jonathan T. Bvunzawabaya, Kennedy J. Ngwira, Fanuel Lampiao, Reuben Maghembe, Hedmon Okella, Anke weisheit, Casim U. Tolo, Patrick E. Ogwang, Duncan C. Sesaazi
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Scientific African
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468227621001289
id doaj-9dd3b57134704c0a8c26e005f95d50fd
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Andrew G. Mtewa
Jonathan T. Bvunzawabaya
Kennedy J. Ngwira
Fanuel Lampiao
Reuben Maghembe
Hedmon Okella
Anke weisheit
Casim U. Tolo
Patrick E. Ogwang
Duncan C. Sesaazi
spellingShingle Andrew G. Mtewa
Jonathan T. Bvunzawabaya
Kennedy J. Ngwira
Fanuel Lampiao
Reuben Maghembe
Hedmon Okella
Anke weisheit
Casim U. Tolo
Patrick E. Ogwang
Duncan C. Sesaazi
Ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with Β-ketoacyl-Acp synthase (KasA) in potential anti-tubercular drug designing
Scientific African
Ligand efficiency
β-ketoacyl-ACP synthase
Drug design
KasA inhibitor
Drug-protein interactions
M. tuberculosis
author_facet Andrew G. Mtewa
Jonathan T. Bvunzawabaya
Kennedy J. Ngwira
Fanuel Lampiao
Reuben Maghembe
Hedmon Okella
Anke weisheit
Casim U. Tolo
Patrick E. Ogwang
Duncan C. Sesaazi
author_sort Andrew G. Mtewa
title Ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with Β-ketoacyl-Acp synthase (KasA) in potential anti-tubercular drug designing
title_short Ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with Β-ketoacyl-Acp synthase (KasA) in potential anti-tubercular drug designing
title_full Ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with Β-ketoacyl-Acp synthase (KasA) in potential anti-tubercular drug designing
title_fullStr Ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with Β-ketoacyl-Acp synthase (KasA) in potential anti-tubercular drug designing
title_full_unstemmed Ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with Β-ketoacyl-Acp synthase (KasA) in potential anti-tubercular drug designing
title_sort ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with β-ketoacyl-acp synthase (kasa) in potential anti-tubercular drug designing
publisher Elsevier
series Scientific African
issn 2468-2276
publishDate 2021-07-01
description Mycobacterium tuberculosis remains one of the world's contributors to mortality. With the emergence of SARS-CoV-2 coinfections, patients with TB are predisposed to being more heavily weighed down by COVID-19 disease and its opportunistic coinfections. The severity of the disease coupled with drug resistance on the currently used drugs warrants for the search for alternative remedies from synthetic agents, semisynthetics and natural products that include plants. Africa is rich in plant diversity with a promise as sources of drug agents, one of which is Eichhornia crassipes. This work aimed at isolating a fatty acid and dock it to β-ketoacyl-ACP synthase for possible anti-TB drug development prospects using computational tools. (9z,12z)-Octadeca-9,12-dienoic acid was isolated from Eichhornia crassipes for the first time using chromatographic techniques and identified using 1D and 2D NMR spectroscopic methods (1H NMR, COSY, HSQC, HMBC and 13C NMR). The compound was then docked to β-ketoacyl-ACP synthase (KasA), an essential member of the b-ketoacyl synthases encoded in the M. tuberculosis genome in comparison with its co-crystallized ligand JSF-3285, also for the first time. (9z,12z)-Octadeca-9,12-dienoic acid interacted with only phenylalanine239 and proline201 while JSF-3285 interacted with proline201, glutamine120, alanine119, leucine116, glutamine199, histadine345, phenylalanine239, glycine240 and glycine200. (9z,12z)-Octadeca-9,12-dienoic acid had a ligand efficiency of 0.24, compared to the co-crystallized ligand's 0.36. The compound was too flexible and elongated with -4.72 KCalmol−1 binding energy. Despite some unfavourable physico-chemical properties, the compound still provides reliable interactions that only require logical structural modifications by the addition of polar regions amongst others to increase interactions and ligand efficiency, which can consequently stand to be a better potential drug lead. For the first time, plant-based (9z,12z)-Octadeca-9,12-dienoic acid isolated from Eichhornia crassipes was shown to interact fairly well with β-ketoacyl-ACP synthase and proved to be a potential starting material from which anti-tubercular drugs can be designed.
topic Ligand efficiency
β-ketoacyl-ACP synthase
Drug design
KasA inhibitor
Drug-protein interactions
M. tuberculosis
url http://www.sciencedirect.com/science/article/pii/S2468227621001289
work_keys_str_mv AT andrewgmtewa ligandproteininteractionsofplantisolated9z12zoctadeca912dienoicacidwithbketoacylacpsynthasekasainpotentialantituberculardrugdesigning
AT jonathantbvunzawabaya ligandproteininteractionsofplantisolated9z12zoctadeca912dienoicacidwithbketoacylacpsynthasekasainpotentialantituberculardrugdesigning
AT kennedyjngwira ligandproteininteractionsofplantisolated9z12zoctadeca912dienoicacidwithbketoacylacpsynthasekasainpotentialantituberculardrugdesigning
AT fanuellampiao ligandproteininteractionsofplantisolated9z12zoctadeca912dienoicacidwithbketoacylacpsynthasekasainpotentialantituberculardrugdesigning
AT reubenmaghembe ligandproteininteractionsofplantisolated9z12zoctadeca912dienoicacidwithbketoacylacpsynthasekasainpotentialantituberculardrugdesigning
AT hedmonokella ligandproteininteractionsofplantisolated9z12zoctadeca912dienoicacidwithbketoacylacpsynthasekasainpotentialantituberculardrugdesigning
AT ankeweisheit ligandproteininteractionsofplantisolated9z12zoctadeca912dienoicacidwithbketoacylacpsynthasekasainpotentialantituberculardrugdesigning
AT casimutolo ligandproteininteractionsofplantisolated9z12zoctadeca912dienoicacidwithbketoacylacpsynthasekasainpotentialantituberculardrugdesigning
AT patrickeogwang ligandproteininteractionsofplantisolated9z12zoctadeca912dienoicacidwithbketoacylacpsynthasekasainpotentialantituberculardrugdesigning
AT duncancsesaazi ligandproteininteractionsofplantisolated9z12zoctadeca912dienoicacidwithbketoacylacpsynthasekasainpotentialantituberculardrugdesigning
_version_ 1721222780193603584
spelling doaj-9dd3b57134704c0a8c26e005f95d50fd2021-08-04T04:20:22ZengElsevierScientific African2468-22762021-07-0112e00824Ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with Β-ketoacyl-Acp synthase (KasA) in potential anti-tubercular drug designingAndrew G. Mtewa0Jonathan T. Bvunzawabaya1Kennedy J. Ngwira2Fanuel Lampiao3Reuben Maghembe4Hedmon Okella5Anke weisheit6Casim U. Tolo7Patrick E. Ogwang8Duncan C. Sesaazi9Chemistry Section, Department of Applied Studies, Institute of Technology, Malawi University of Science and Technology, Malawi; Pharmbiotechnology and Traditional Medicine Centre (PHARMBIOTRAC), Mbarara University of Science and Technology, Mbarara, Uganda; Corresponding author at: Chemistry Section, Department of Applied Sciences, Institute of Technology, Malawi University of Science and Technology, Malawi.Department of Biomedical Sciences, Kamuzu University of Health Sciences, Blantyre, Malawi; Africa Centre of Excellence in Public Health and Herbal Medicine (ACEPHEM), Kamuzu University of Health Sciences, MalawiSchool of Chemistry, Institute of Molecular Science, University of Witwatersrand, South AfricaDepartment of Biomedical Sciences, Kamuzu University of Health Sciences, Blantyre, Malawi; Africa Centre of Excellence in Public Health and Herbal Medicine (ACEPHEM), Kamuzu University of Health Sciences, MalawiBiotechnology Section, Centre for Chemistry and Chemical Engineering, Lund University, Lund, Sweden; Marian University College, Department of Biological and Marine Sciences, Bagamoyo, TanzaniaPharmbiotechnology and Traditional Medicine Centre (PHARMBIOTRAC), Mbarara University of Science and Technology, Mbarara, UgandaPharmbiotechnology and Traditional Medicine Centre (PHARMBIOTRAC), Mbarara University of Science and Technology, Mbarara, UgandaPharmbiotechnology and Traditional Medicine Centre (PHARMBIOTRAC), Mbarara University of Science and Technology, Mbarara, UgandaPharmbiotechnology and Traditional Medicine Centre (PHARMBIOTRAC), Mbarara University of Science and Technology, Mbarara, UgandaPharmbiotechnology and Traditional Medicine Centre (PHARMBIOTRAC), Mbarara University of Science and Technology, Mbarara, UgandaMycobacterium tuberculosis remains one of the world's contributors to mortality. With the emergence of SARS-CoV-2 coinfections, patients with TB are predisposed to being more heavily weighed down by COVID-19 disease and its opportunistic coinfections. The severity of the disease coupled with drug resistance on the currently used drugs warrants for the search for alternative remedies from synthetic agents, semisynthetics and natural products that include plants. Africa is rich in plant diversity with a promise as sources of drug agents, one of which is Eichhornia crassipes. This work aimed at isolating a fatty acid and dock it to β-ketoacyl-ACP synthase for possible anti-TB drug development prospects using computational tools. (9z,12z)-Octadeca-9,12-dienoic acid was isolated from Eichhornia crassipes for the first time using chromatographic techniques and identified using 1D and 2D NMR spectroscopic methods (1H NMR, COSY, HSQC, HMBC and 13C NMR). The compound was then docked to β-ketoacyl-ACP synthase (KasA), an essential member of the b-ketoacyl synthases encoded in the M. tuberculosis genome in comparison with its co-crystallized ligand JSF-3285, also for the first time. (9z,12z)-Octadeca-9,12-dienoic acid interacted with only phenylalanine239 and proline201 while JSF-3285 interacted with proline201, glutamine120, alanine119, leucine116, glutamine199, histadine345, phenylalanine239, glycine240 and glycine200. (9z,12z)-Octadeca-9,12-dienoic acid had a ligand efficiency of 0.24, compared to the co-crystallized ligand's 0.36. The compound was too flexible and elongated with -4.72 KCalmol−1 binding energy. Despite some unfavourable physico-chemical properties, the compound still provides reliable interactions that only require logical structural modifications by the addition of polar regions amongst others to increase interactions and ligand efficiency, which can consequently stand to be a better potential drug lead. For the first time, plant-based (9z,12z)-Octadeca-9,12-dienoic acid isolated from Eichhornia crassipes was shown to interact fairly well with β-ketoacyl-ACP synthase and proved to be a potential starting material from which anti-tubercular drugs can be designed.http://www.sciencedirect.com/science/article/pii/S2468227621001289Ligand efficiencyβ-ketoacyl-ACP synthaseDrug designKasA inhibitorDrug-protein interactionsM. tuberculosis